Gene Query: ARHGAP15

Dataset Description Geneva Score
SRSF2 mutations impair hematopoiesis and alter exon recognition 45.54
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 44.29
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 44.29
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 30.31
Total RNA-seq in ALL-SIL upon JQ1 inhibition 26.87
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 26.71
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 21.48
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 19.49
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 18.86
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 18.27
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 17.94
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 17.21
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 16.55
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 16.55
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 16.52
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 15.5
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 15.46
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 14.73
Transcriptome-wide identification of CELF2 functional targets in T cells 14.72
Reassessment of Exosome Composition 13.73
Gene expression changes associated with resistance to tagraxofusp (SL-401) 13.62
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 13.53
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 13.39
circRNA-sequencing 13.31
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 13.23
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 13.18
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 13.18
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 13.18
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 13.14
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 13.14
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 12.68
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 12.46
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 12.44
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 12.28
Transcriptional profiles of normal human mature B cells 11.96
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 11.88
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 11.64
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 11.62
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 11.59
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 11.58
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 11.38
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 11.38
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 11.11
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 11.04
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 11.04
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.95
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 10.88
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 10.88
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 10.77
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 10.7
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 10.63
Landscape of H3K4me3 in human CD19 cells 10.36
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 10.21
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 10.21
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 9.95
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 9.93
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 9.88
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 9.88
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 9.84
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 9.8
RNA-sequencing of formalin fixed human primary melanoma tissue 9.78
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 9.78
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 9.74
Seletive inhibition of CDK9 in DLBCL cell lines 9.74
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.57
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 9.52
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 9.38
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 9.3
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 9.3
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 9.28
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 9.25
Transcriptome of activated human and mouse MAIT cells 9.22
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.16
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 9.13
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 9.05
CROP-Seq in Primary Human T Cells 8.93
Transcriptional profiling of microglia; current state of the art and future perspectives 8.89
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 8.84
mRNA expression profile of Lymphocytes 8.68
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 8.59
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 8.58
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 8.58
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 8.47
Short and Long RNA sequencing of human mature erythrocytes 8.3
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 8.3
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 8.08
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 7.98
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 7.97
Developmental stage specific chromosome architecture in human erythroid cells 7.97
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 7.91
RNA-seq of resting and activated CD4+ T cells +-JQ1 7.82
Human Treg IL-12 stimulation 7.75
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.72
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 7.36
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 7.2
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 7.14
RNA sequencing of matched nephrectomy samples [RNA-seq] 7.14
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 7.12
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 7.11
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 7.08
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 7.08
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.94
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 6.93
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 6.83
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 6.77
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.76
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 6.72
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 6.66
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 6.63
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 6.61
Aortic Valve Tissue: Stenosis vs. Sclerosis 6.55
Human cell line and subcutaneous tumor 6.5
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 6.49
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 6.49
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 6.47
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 6.32
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.27
The Human Testis Cell Atlas via Single-cell RNA-seq 6.21
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 6.19
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 6.18
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 6.12
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 6.12
MeRIP-seq for heat shock in B-cell lymphoma cells 6.11
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 6.08
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 6.07
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 6.02
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 6.0
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.93
Intron retention induced by microsatellite expansions as a disease biomarker. 5.79
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 5.76
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 5.75
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 5.75
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 5.74
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.66
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 5.65
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 5.59
T47D RNA-seq and ChrRNA-seq data 5.55
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.55
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 5.54
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 5.52
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 5.48
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 5.45
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 5.45
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 5.43
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 5.41
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.4
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.4
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 5.31
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 5.19
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 5.18
Non-coding regions are the main source of tumor-specific antigens [human] 5.09
Non-coding regions are the main source of tumor-specific antigens 5.09
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 5.01
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 5.01
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 4.98
Widespread regulated alternative splicing of single codons accelerates proteome evolution 4.97
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 4.96
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 4.95
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 4.92
The pioneer factor CEBPA modulates vitamin D signaling 4.92
Trans-differentiation of human adult peripheral blood T cells into neurons 4.92
Landscape and variation of RNA secondary structure across the human transcriptome 4.9
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 4.89
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 4.85
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 4.85
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.83
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 4.8
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 4.76
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.7
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 4.66
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.64
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 4.63
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.63
SOX11 knockdown in B-ALL cell lines 4.57
RNAseq of T-ALL upon long non coding rna purturbation 4.53
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 4.52
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 4.52
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 4.51
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 4.47
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 4.47
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 4.45
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 4.42
Identification of renal resident macrophages across species 4.4
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 4.38
Intrahepatic MAIT cell gene expression revealed by RNA-seq 4.34
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.33
RNA-seq analysis of AML cells in response to ASLAN003 4.32
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 4.29
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 4.26
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 4.26
Gene expression profiling of leukemia cells following asparagine depletion 4.26
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 4.25
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 4.25
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 4.15
JAK dependent survival of ALK- ALCL 4.14
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 4.14
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 4.14
Single cell transcriptome of peritoneal cells 4.12
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 4.09
Macrophage Ad5f35 M2 Challenge 4.09
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.06
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.01
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.99
RNA-seq data 3.94
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 3.91
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 3.85
naive T cell heterogeneity after neonatal thymectomy 3.84
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 3.84
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.78
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 3.78
MYC dependent mRNA translation shapes gene expression and cell biology 3.78
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.76
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 3.7
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.68
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.68
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 3.68
mRNA expression profile of Lymphocytes by high-throuput sequencing 3.63
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.61
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 3.54
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 3.54
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.47
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.46
The pause-initiation limit restricts transcription activation in human cells 3.45
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 3.43
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 3.43
Expression and functions of long noncoding RNAs during human T helper cell differentiation 3.4
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 3.34
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.32
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 3.24
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 3.24
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 3.23
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 3.23
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 3.23
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 3.23
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.22
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 3.18
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 3.16
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 3.16
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.16
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 3.12
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.12
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.12
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.12
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 3.1
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 3.02
Loss of CREBBP results in gene expression repression in lymphoma cells 3.02
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.02
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.99
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 2.99
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 2.97
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 2.95
CircRNAome diversity in human mature B-cells, T-cells and monocytes 2.95
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.94
siRNA-mediated knockdown 2.93
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 2.92
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.89
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.87
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.87
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 2.81
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 2.81
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 2.81
Transcriptome analysis of SKI knock-out in HL60 cells 2.79
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.79
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 2.79
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 2.79
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.79
Transcriptome of diurnal human blood neutrophils 2.77
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 2.76
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.74
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.73
Human cells contain natural double-stranded RNAs with potential regulatory capacity 2.72
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.72
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.72
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.7
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 2.66
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.66
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 2.64
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.63
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.62
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 2.6
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 2.59
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 2.58
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.56
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 2.53
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.5
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.5
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 2.44
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 2.44
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 2.43
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.42
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 2.41
TAF1 is critical for AE driven leukemogenesis 2.36
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.36
LncRNA expression profiling of ischemic stroke patients 2.35
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.35
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.35
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.34
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 2.32
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.31
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.26
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 2.24
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.24
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.19
Transcription elongation regulates genome 3D structure 2.19
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 2.19
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 2.19
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 2.17
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 2.17
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 2.16
Transcriptomic analysis of human tonsillar TFH subsets 2.15
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.14
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 2.14
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.14
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 2.14
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 2.12
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.1
Transcription control by the ENL YEATS domain in acute leukemia 2.09
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.09
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 2.08
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.06
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.06
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.06
RNA-Seq and expression data from human adipose tissue 2.06
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.06
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 2.05
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 2.01
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.0
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 1.94
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 1.94
BCL11B 1.94
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.93
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.93
Characterization of human ILC2 subsets 1.92
Human Treg IFNg/IL-10 subpopulations 1.9
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.9
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.88
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.88
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 1.87
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.86
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.82
Transcriptomic profiling of human peripheral blood-derived mast cells 1.82
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.82
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.8
The transcriptome of Kawasaki Disease arteritis 1.77
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 1.77
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.75
Transcriptomes in healthy and CHB fetal hearts 1.73
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.72
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.71
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.69
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 1.69
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.69
Dysregulated immune system networks in war veterans with PTSD 1.67
Targeted enhancer activation by a subunit of the integrator complex 1.61
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 1.59
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 1.59
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.59
The expression profiles of GBC liver metastasis 1.58
BACH2 in human plasma cell fate decision 1.58
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.57
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.56
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.55
Expression patterns in chronic thromboembolic pulmonary hypertension 1.55
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.54
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.54
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.52
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.51
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.51
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 1.49
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 1.4
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.39
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.38
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.36
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 1.34
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.3
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.3
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.3
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.29
Anti-inflammatory effect of indoleacrylic acid (IA) 1.26
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.25
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 1.24
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 1.23
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.21
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.19
Polarized B -cell functions 1.19
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.19
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.17
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.17
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 1.16
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.13
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.13
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.12
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.1
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.1
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 1.07
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.06
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.06
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.04
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.03
Specific molecular signatures underlie response to decitabine in CMML 1.03
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.02
Functional significance of the HIV-1 Tat signature amino acid residues 1.02
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.02
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.02
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.0
Fibroblasts in cholesteatoma activate osteoclasts. 0.98
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.98
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.97
Aging-associated patterns in the expression of human endogenous retroviruses 0.95
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.92
Transcriptome sequencing of K-562 cells 0.92
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.9
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.9
HEK293 Heat-shock experiment 0.89
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.88
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 0.88
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.88
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.87
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.84
The DNA methylation landscape of human melanoma [RNA-Seq] 0.82
The DNA methylation landscape of human melanoma 0.82
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.8
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 0.8
Common inflammatory pathways between NEC and Crohn's disease 0.78
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.75
Transcriptome analysis of CNS leukemia 0.72
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.72
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.71
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.69
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.69
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.68
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.65
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 0.64
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.64
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.62
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.61
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.6
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.59
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 0.58
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.55
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.53
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.53
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.52
CD74 role in transcription regulation 0.51
CD74 role in transcription regulation [RNA-seq] 0.51
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.5
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.5
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.49
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 0.48
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 0.48
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.47
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.45
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.42
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 0.42
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 0.42
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.41
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.41
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.39
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.37
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.37
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.36
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.36
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 0.34
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 0.34
Impact on erythroid progenitor type on erythroid differntiation 0.29
Gene expression of collecting duct carcinoma of the kidney 0.27
RNA-seq of primary patient AML samples 0.27
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.27
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.27
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.27
Global transcriptome analysis of WT versus HEB-/- hESCs 0.25
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.24
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.24
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.21
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.21
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.2
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 0.18
Reprogrammed myeloid cell transcriptomes in NSCLC 0.18
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.17
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.17
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.17
Gene expression profiling in metabolically heterogeneous human lung tumors 0.16
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.15
A single-cell transcriptome atlas of the human pancreas 0.13
Human Tfh cell RNA bulk sequencing 0.12
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.11
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.11
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.1
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.09
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.08
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.08
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.07
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.07
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.06
Gene expression activation in CLL mediated by MSCs contact 0.06
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.05
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.02
RNA-seq of CD33 KO and control HSPCs 0.02
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.01
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation